Senior Analyst at Intertek. I am a highly motivated and versatile scientist with extensive experience in various scientific disciplines, including pharmacokinetics, immunogenicity assays, and immune system characterisation. With a strong foundation in both academic research and industry practice, I specialise in bioanalytical methodologies to support drug development and ensure the delivery of high-quality data. Currently, as a Senior Analyst at Intertek Pharmaceutical Services, I lead and execute complex assays focusing on immunogenicity, pharmacokinetics, and biomarker analysis. I work with cutting-edge analytical platforms to ensure compliance with ICH M10 and FDA/EMA regulations. My work is driven by a commitment to data integrity, regulatory excellence, and a patient-centric approach to the development of safe and effective therapeutic solutions. During my PhD in Pharmacy and Pharmacology at the University of Bath, I developed a deep understanding of protein-based therapeutics, by designing and developing innovative assays to evaluate the immune response. My research investigated critical factors like anti-drug antibodies and the impact of mAb degradation, aiming to enhance drug safety, efficacy, and long-term therapeutic outcomes. With a comprehensive skill set spanning bioanalytical method development, clinical pharmacology, immunology, and regulatory compliance, I am driven to contribute to the advancement of precision medicine and therapeutic innovations that positively impact patient outcomes.